AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients - Concepedia

Concepedia

Publication | Closed Access

AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients

66

Citations

25

References

2013

Year

Kévin Martin, Karen Pickthorn, Saling Huang, Geoffrey A. Block, Andrew Vick, Peter F. Mount, David A. Power, Gregory Bell

Kidney International

HemodialysisSecondary HyperparathyroidismRenal FunctionHemodialysis PatientsMedicineParathyroid HormonePharmacologyParathyroid DiseaseNovel PeptideChronic Kidney DiseaseNephrology

References

	Year	Citations

Page 1

Page 1